In the News

2020

With little access to doctors, drug firms go digital to stay relevant
June 13, 2020 - Business Standard

Urgent action required to revive the pharma ancillary industry: IPA
June 8, 2020 - Economic Times

‘API package’s led to some hope but government involvement’s essential
June 5, 2020 - The Times of India

Modi’s ‘self-reliance’ call need of the hour: Pharma industry
May 13, 2020 - Business Standard

Govt to develop platform to monitor HCQ availability amid reports of supply crunch
April 13, 2020 - Hindustan Times

Coronavirus: the high-voltage drug industry in India
April 11, 2020 - Le Monde (French)

Bulk drugs: Pharma’s pain point
April 10, 2020 - Forbes India

India’s Drugmakers Ramp Up Production Of ‘Game-Changer’ Coronavirus Drug Hydroxychloroquine
April 9, 2020 - Forbes India

IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19
April 6, 2020 - IPA

IPA Press Statement on Promotion of Domestic Manufacturing of APIs and KSMs Policy
March 22, 2020 - IPA

IPA’s statement on Covid-19 and the commitment to be a reliable partner for supply of medicines
March 21, 2020 - IPA

Indian Pharmaceutical Alliance’s 5th India Pharmaceutical Forum highlights Patient Centricity and Integrated Quality Management
February 28, 2020 - IPA

Coronavirus outbreak: China shutdown to hit Indian drug manufacturers
January 31, 2020 - Business Today

Pharma firms brace for raw material supply issues due to coronavirus outbreak
January 30, 2020 - Mint

‘Coronavirus, a wake-up call to reduce reliance on Chinese pharma intermediates
January 30, 2020 - The Hindu Business Line